| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 685794 | Null | 0.00163653239752573 | 0.14245419 |
| NSC 697569 | Null | 0.00163653239752573 | 0.37260238 |
| NSC 727985 | NSC 708781 incorporated in micelles, 0.55% (w/w) of drug | 0.00163653239752573 | 0.34343948 |
| NSC 730460 | 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate | 0.00163653239752573 | 0.3261955 |
| NSC 731155 | 6-(3-Aminopropyl)-5,6-dihydro-5,11-dioxo-3-nitro-11H-indeno[ 1,2-c]isoquinoline Hydrochloride salt | 0.00163653239752573 | 0.2102733 |
| NSC 251805 | Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester | 0.00172065213317242 | 0.068575128 |
| NSC 638646 | 4-Piperidinone, 3,5-bis[(3,4-dichlorophenyl)methylene]- 1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride | 0.00172065213317242 | 0.38998439 |
| NSC 639978 | Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride | 0.00172065213317242 | 0.29881552 |
| NSC 680781 | 2(3H)-Furanone, dihydro-3-[1-[(4-chlorophenyl)amino] ethylidene]- | 0.00172065213317242 | 0.33383668 |
| NSC 762934 | Null | 0.00172065213317242 | -0.32848336 |